Aarti Pharmalabs Limited — Updates, 08-10-2025: General Updates
08-10-2025 | 10:58 am
08-10-2025 | 10:58 am
Aarti Pharmalabs received a court injunction stopping production/sale of a Ruxolitinib-based drug due to alleged patent infringement. Company confirms operations remain unaffected, with no financial impact from this development.
No comments yet. Be the first to comment!
